Nutrabiosys Inc. (OTC Pink Sheets: NTBS)—has completed an agreement to market, distribute and promote an all natural antidepressant alternative to prescription drugs such as Paxil, Prozac and Zoloft. The agreement was negotiated with a well known Neutraceutical Health Company that Nutrabiosys has developed an ongoing business relationship with.
Nutrabiosys, will make available the revolutionary all natural product Anxius. Anxius is a herbal supplement that works to supply your brain with the repair tools needed to bring your neurotransmitter levels back to a healthy balance. The working ingredients in Anxius(TM) will provide the exact nutrient supplements that your brain requires to be able to correct itself within days and even hours. Anxius(TM) has been designed to be safe enough to take on a permanent basis, yet potent enough to not only treat, but prevent you from relapsing to depression, anxiety and chronic stress in the future.
The product will be available through various retail channels including new internet “cyber-distribution outlets” that are currently being constructed by the Company. Nutrabiosys decision was motivated by the ongoing public awareness that prescribed antidepressant drugs typically come with numerous side effects. Zoloft, a FDA approved medication used for treating depression and social anxiety disorders sales totaled $3.3 billion in 2005. Some of the most common side effects from such drugs are dizziness, nausea, decreased sex drive and anxiety.
There are more than 45 million people taking antidepressant drugs or SSRl’s and millions more considering using it. Anxius (TM) is a natural herbal supplement, affordably priced and available without prescription. An overwhelming 90% have reported major improvements in their depression, anxiety and overall mood disorders within days, some within 24 hours of treatment by using Anxius(TM) supplements.
Reliable and medically approved with no side effects! Anxius(TM) comes with a satisfaction money back guarantee and should be available through our internet cyber-distribution outlets by early June 2007.
NutraBiosys Inc. is a winning nutraceutical biotech company committed to the discovery and development of breakthrough small molecule natural products for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major Nutraceutical and Biotech companies. NutraBiosys product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward- looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.
Nutrabiosys Inc.
